Publikationen, an denen er mitarbeitet Yosef Yarden (4)

2021

  1. Egfr in cancer: Signaling mechanisms, drugs and acquired resistance

    Cancers, Vol. 13, Núm. 11

  2. Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors

    Cancer Research, Vol. 81, Núm. 14, pp. 3862-3875

  3. TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis

    Science Signaling, Vol. 14, Núm. 688

  4. Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models

    EMBO Molecular Medicine, Vol. 13, Núm. 4